Monitoring and evaluation of PEPFAR treatment programmes

The Lancet

Volumn 374, Issue 9696, 2009, Pages 1146-1147

  Holmes, Charles B ^a   Williams Sherlock, Michelle A ^a   Bouey, Paul D ^a  

^a PEPFAR   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

HEALTH CARE ACCESS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL;

DATA COLLECTION; DRUG MONITORING; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; PATIENT DROPOUTS; PROGRAM EVALUATION; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH;

EID: 70349495193     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61741-4     Document Type: Letter

References (1)

1. Navario P. PEPFAR's biggest success is also its largest liability. Lancet 374 (2009) 184-185